Clostridioides difficile Infection in a Japanese Tertiary Children's Hospital |
Meguro, Mariko
(Division of Gastroenterology and Hepatology, Saitama Children's Medical Center)
Nambu, Ryusuke (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) Hara, Tomoko (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) Ebana, Ryo (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) Yoshida, Masashi (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) Yamamoto, Saki (Department of Laboratory Technology, Saitama Children's Medical Center) Mori, Koki (Department of Laboratory Technology, Saitama Children's Medical Center) Iwama, Itaru (Division of Gastroenterology and Hepatology, Saitama Children's Medical Center) |
1 | Corrigan RA, Sithamparanathan K, Kenny C, Wong THN. Usefulness of the Bristol Stool Form Chart scoring system for the laboratory processing of faecal samples in suspected Clostridioides difficile cases. J Hosp Infect 2020;105:95-7. DOI |
2 | Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile Infection in children. JAMA Pediatr 2013;167:567-73. DOI |
3 | Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficileinfection (CDI). Clin Microbiol Infect 2009;15:1053-66. DOI |
4 | Kawada M, Annaka M, Kato H, Shibasaki S, Hikosaka K, Mizuno H, et al. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection. J Infect Chemother 2011;17:807-11. DOI |
5 | Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46 (Suppl 1):S12-8. DOI |
6 | Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405-10. DOI |
7 | Guidelines for the treatment of Clostridioides (Clostridium) difficile infections [Internet]. Tokyo: CDI Clinical Practice Guideline Development Committee; 2018 [cited 2022 Apr 21]. Available from: https://www.chemotherapy.or.jp/modules/guideline/index.php?content_id=96#pdf |
8 | Revolinski SL, Munoz-Price LS. Clostridium difficile in immunocompromised hosts: a review of epidemiology, risk factors, treatment, and prevention. Clin Infect Dis 2019;68:2144-53. DOI |
9 | Perumalsamy S, Riley TV. Molecular epidemiology of Clostridioides difficile infections in children. J Pediatric Infect Dis Soc 2021;10 (Suppl 3):S34-40. DOI |
10 | Martinelli M, Strisciuglio C, Veres G, Paerregaard A, Pavic AM, Aloi M, et al. Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis 2014;20:2219-25. DOI |
11 | van Prehn J, Vandenbroucke-Grauls CM, van Beurden YH, van Houdt R, Vainio S, Ang CW. Diagnostic yield of repeat sampling with immunoassay, real-time PCR, and toxigenic culture for the detection of toxigenic Clostridium difficile in an epidemic and a non-epidemic setting. Eur J Clin Microbiol Infect Dis 2015;34:2325-30. DOI |
12 | Schroeder MS. Clostridium difficile--associated diarrhea. Am Fam Physician 2005;71:921-8. |
13 | Deshpande A, Pasupuleti V, Patel P, Ajani G, Hall G, Hu B, et al. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol 2011;9:665-9.e1. DOI |
14 | Gnocchi M, Gagliardi M, Gismondi P, Gaiani F, De' Angelis GL, Esposito S. Updated management guidelines for Clostridioides difficile in paediatrics. Pathogens 2020;9:291. |
15 | Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013;26:604-30. DOI |
16 | Senoh M, Kato H, Honda H, Fukuda T, Tagashira Y, Horiuchi H, et al. Performance of laboratory tests for detection for Clostridioides difficile: a multicenter prospective study in Japan. Anaerobe 2019;60:102107. |
17 | Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198-208. Erratum in: N Engl J Med 2022;386:2348. |
18 | Salamonowicz M, Ociepa T, Fraczkiewicz J, Szmydki-Baran A, Matysiak M, Czyzewski K, et al. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation. Eur J Clin Microbiol Infect Dis 2018;37:1805-12. DOI |
19 | Wilcox MH. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 2003;17:475-93. DOI |
20 | Gateau C, Couturier J, Coia J, Barbut F. How to: diagnose infection caused by Clostridium difficile. Clin Microbiol Infect 2018;24:463-8. DOI |
21 | Yin J, Kociolek LK, Same RG, Hsu AJ, Amoah J, Tamma PD. Oral vancomycin may be associated with earlier symptom resolution than metronidazole for hospitalized children with nonsevere Clostridiodes difficile infections. Open Forum Infect Dis 2019;6:ofz492. Erratum in: Open Forum Infect Dis 2020;7:ofaa041. |
22 | Senoh M, Kato H, Fukuda T, Niikawa A, Hori Y, Hagiya H, et al. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf ) of Clostridium difficile in Japan: a potential relationship with other global circulating strains? J Med Microbiol 2015;64:1226-36. DOI |
23 | Chandrakumar A, Zohni H, El-Matary W. Clostridioides difficile infection in children with inflammatory bowel disease. Inflamm Bowel Dis 2020;26:1700-6. DOI |
![]() |